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Abstract 
BACKGROUND: A substantial increase in substance treatment episodes for methamphetamine problems 
suggests characteristics of the treatment population could have changed and that targeted treatment 
programs are required. To determine who methamphetamine treatment should be designed for this study 
has two aims. First, to empirically describe changes in amphetamine treatment presentations to a rural 
NSW drug and alcohol treatment agency over time. Second, to examine how these characteristics may 
affect the likelihood of being treated for amphetamines compared to other drugs. METHOD: The 
Australian Alcohol and Other Drug Treatment Services National Minimum Data Set (AODTS-NMDS) 
containing closed treatment episodes from a single agency from three time periods was used. 
Characteristics of people receiving amphetamine treatments in these three periods were compared and 
the effects of these characteristics on the odds of being treated for amphetamine were estimated using a 
logistic regression model. The characteristics utilised in the analysis include age, sex, Indigenous status, 
usual accommodation, living arrangement, source of referral and source of income. RESULTS: The 
proportion of amphetamine treatment episodes doubled from 2006/2007 to 2015/2016 and overtook 
alcohol as the most commonly treated principal drug of concern. The estimated proportion of 
amphetamine treatments showed an increment across all ages and for men and women. It was found 
that younger people, women, people in temporary accommodation or homeless, people who were self-
referred and people whose main source of income was not through employment are more likely to be 
treated for amphetamine use. CONCLUSION: Significant changes over time in the age, sex and Indigenous 
status of people receiving treatment for amphetamine as the principal drug of concern requires service 
delivery to match demand from younger people, particularly women; and Indigenous people. The needs 
and preferences for treatment of younger women who use amphetamine will be important factors in 
treatment planning service providers who are more used to providing treatment for young men who use 
cannabis and older men who use alcohol. Further research on women's experiences in treatment and 
outcomes would be useful for informing treatment practices. 
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treatment in rural Australia
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Abstract 
Background: A substantial increase in substance treatment episodes for methamphetamine problems suggests 
characteristics of the treatment population could have changed and that targeted treatment programs are required. 
To determine who methamphetamine treatment should be designed for this study has two aims. First, to empirically 
describe changes in amphetamine treatment presentations to a rural NSW drug and alcohol treatment agency over 
time. Second, to examine how these characteristics may affect the likelihood of being treated for amphetamines com-
pared to other drugs.
Method: The Australian Alcohol and Other Drug Treatment Services National Minimum Data Set (AODTS-NMDS) 
containing closed treatment episodes from a single agency from three time periods was used. Characteristics of peo-
ple receiving amphetamine treatments in these three periods were compared and the effects of these characteristics 
on the odds of being treated for amphetamine were estimated using a logistic regression model. The characteristics 
utilised in the analysis include age, sex, Indigenous status, usual accommodation, living arrangement, source of refer-
ral and source of income.
Results: The proportion of amphetamine treatment episodes doubled from 2006/2007 to 2015/2016 and overtook 
alcohol as the most commonly treated principal drug of concern. The estimated proportion of amphetamine treat-
ments showed an increment across all ages and for men and women. It was found that younger people, women, 
people in temporary accommodation or homeless, people who were self-referred and people whose main source of 
income was not through employment are more likely to be treated for amphetamine use.
Conclusion: Significant changes over time in the age, sex and Indigenous status of people receiving treatment for 
amphetamine as the principal drug of concern requires service delivery to match demand from younger people, 
particularly women; and Indigenous people. The needs and preferences for treatment of younger women who use 
amphetamine will be important factors in treatment planning service providers who are more used to providing 
treatment for young men who use cannabis and older men who use alcohol. Further research on women’s experi-
ences in treatment and outcomes would be useful for informing treatment practices.
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Introduction
Australian media has reported an ice epidemic sweep-
ing the country since the beginning of 2014. “Ice” 
is slang for crystal methamphetamine, a stimulant 
drug that is swallowed, smoked or injected. Meth-
amphetamine use is not an epidemic in Australia. 
The population level use of methamphetamine has 
decreased from 2.1% in 2013 to 1.4% in 2016 [1]. How-
ever, those who use methamphetamine are using higher 
purity products more frequently and experiencing more 
negative consequences as a result [2]. Deaths from 
methamphetamine have doubled since 2009 and health 
impacts including heart problems and stroke have 
increased [3]. Significantly higher methamphetamine 
use is reported in rural and remote Australia compared 
to urban locations [4]. Hereafter the term used will be 
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amphetamine as it is commonly referred to in Austral-
ian government reports and surveys [1, 5].
There is an increasing need for health services to 
engage with people who use amphetamines [6], and new 
harm minimisation practices and targeted treatment pro-
grams are required relevant to the context of ampheta-
mine users experience [5]. Context is a critical factor 
in healthcare delivery yet is typically under-estimated 
when planning services [7]. Ideally, targeted treatment 
and harm minimisation practices are context specific. 
That is, they should be located close to areas of highest 
need, acceptable to the age, sex and cultural background 
of potential clients; and deliver a comprehensive service 
that does not isolate drug use from a person’s other con-
cerns or needs [8, 9]. For rural populations, interventions 
should be specific to the unique circumstances of rural 
settings [4].
The characteristics of those the program or treatment 
is designed for is one of the key domains in program 
implementation [10]. The characteristics of amphetamine 
users will be important to responding effectively from 
existing treatment services. Detailed examination of who 
is accessing treatment services is required to define who 
amphetamine treatment should be designed for.
The Australian National Drug and Alcohol Treatment 
Data Report provides a broad overview of treatment pro-
vided and drills down to some demographic and drug 
specific factors [11]. However, it does not consider mul-
tiple variables at a time nor provide enough detail for a 
localised approach to substance treatment planning.
An in-depth examination of a single agency is one way 
of contextualising demand for, and supply of substance 
treatment services to appropriately inform service deliv-
ery. Systematically analysing and reporting local data can 
determine which user factors need to be responded to. 
Examining changes over time can shape service provi-
sion in response to changing demand. This study had two 
aims. First, to empirically describe changes in ampheta-
mine treatment presentations to a rural NSW drug and 
alcohol treatment agency over time. Second, to exam-
ine how these characteristics may affect the likelihood 
of being treated for amphetamines compared to other 
drugs.
Study context
Australian drug and alcohol treatment programs are pro-
vided by both government and non-government agen-
cies. The Australian Alcohol and Other Drug Treatment 
Services National Minimum Data Set (AODTS-NMDS) 
measures supply of publicly funded mainstream drug 
and alcohol treatment. AODTS-NMDS data is collected 
by individual agencies and reported to state and terri-
tory health authorities [11]. In New South Wales (NSW) 
one-third of service providers are non-government agen-
cies who provide about half of all treatment episodes in 
the state [11].
Lives Lived Well—NSW (LLW) is a non-government 
drug and alcohol treatment service based in the regional 
NSW town of Orange (2016 population 39,755). Orange 
is a regional centre for agricultural industries includ-
ing apples and wine grapes; gold mining and health care 
facilities including the largest psychiatric hospital in 
NSW. LLW—NSW was established in 1980 with a resi-
dential drug and alcohol rehabilitation centre and had 
expanded by 2004 to also have assessment, residential 
withdrawal, medical and outpatient counselling and case 
management services. LLW—NSW provided around 
2400 treatment episodes annually across the various 
treatment types to men (65% of treatment episodes) and 
women (35%). Two-thirds of people who accessed LLW 
services were from western NSW; and one-third came 
from cities on the coast—usually to inpatient programs. 
All LLW services were government funded from either 
state or commonwealth health departments. Outpatient 
services were free, inpatient withdrawal cost $120 AUD 
per admission and the 90-day residential rehabilitation 
program cost participants $120 AUD per week. Between 
2006 and 2016 the withdrawal fees doubled but the reha-
bilitation fees were reduced by $20 per week as govern-
ment welfare payments decreased and became harder to 
obtain.
National and state governments both provided new 
funding for amphetamine treatment following a series 
of Ice taskforces and Parliamentary Inquiries into the 
prevalence of and harms related to amphetamine use. 
However, it was 2017 before new services or service 
enhancements were funded and they were not consid-
ered a factor in influencing demand in this study. Prior 
to 2017 none of the government funding specified treat-
ment for a type of drug or for a particular group of people 
other than those over eighteen. Services were expected to 
be responsive to demand and provide services consistent 
with the substance treatment evidence base.
Treatment provided by the agency included individ-
ual and group counselling using Cognitive Behavioural 
Therapy and Motivational Interviewing approaches. 
Psycho-educational groups included relapse prevention 
strategies, sexual health, legal advice and financial coun-
selling. The inpatient withdrawal program had medical 
staff who conducted health checks as well as provided 
medication for withdrawal management. The residential 
rehabilitation program also included cognitive remedia-
tion programs for people with cognitive impairments; a 
health and fitness program at a local gym; and arts and 
crafts options including music lessons and drumming. 
Rehabilitation residents were invited to attend the local 
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Alcoholics Anonymous group but meetings were not 
compulsory.
Prior analyses of LLWs treatment episode data have 
identified alcohol (60% of episodes), opioids (18%) and 
cannabis (18%) as the three most common drugs treat-
ment was provided for [12]. The average age of people 
accessing services was thirty-seven. In 2015 LLW staff 
reported increased demand for treatment from people 
who were using amphetamines. People using ampheta-
mines were perceived by staff as having different needs 
for treatment compared to those primarily using depres-
sants and less likely to complete treatment than peo-
ple using other drugs. The perceived differences had 
not been explored. Around the same time researchers 
were arguing against an ‘ice epidemic’ and pointing to 
unchanged population data on drug use that refuted the 
increased harms treatment services were seeing [5, 13].
Lives Lived Well’s research program has used both 
state-wide and local treatment episode data to highlight 
the need for treatment services to address homeless-
ness in treatment planning [12]; identify the prevalence 
of people in treatment who have a cognitive impairment 
[14] and investigate access of Aboriginal women to drug 
and alcohol treatment [15]. To appropriately shape ser-
vice delivery an analysis of amphetamine treatment epi-
sodes was required.
Method
The AODTS-NMDS containing closed treatment epi-
sodes from LLW from July 2006 to June 2007, July 2010 
to June 2011, and January 2015 to June 2016 were used. 
A ten-year period was selected for analysis that com-
menced when a consistent data collection method that 
included checking data quality was implemented. Fur-
ther, increased amphetamine use was reported in 2006 
including the first media references to an ‘ice epidemic’ 
and related government policy responses [16].
The focus was on the principal drug of concern and the 
samples were split into episodes where the principal drug 
of concern was amphetamine and episodes where the 
principal drug of concern included all other drugs. Char-
acteristics, including age, sex, Indigenous status, usual 
accommodation, living arrangement, source of referral, 
and source of income were extracted from the datasets. 
These characteristics among amphetamine treatments 
over the three time periods were compared using the 
Marascuilo’s procedure [17].
The effects of the above characteristics on the odds of 
being treated for amphetamine were assessed using a 
logistic regression model with the three datasets com-
bined. Covariates included the above characteristics, 
time period, and the first-order interaction between 
each pair of time period, age and sex. The logarithm of 
the odds ratio of being treated for amphetamine against 
other drugs was used as the response variable.
For some variables there were several categories that 
occurred rarely in AODTS-NMDS. These categories were 
therefore combined or moved to the “Others” category 
(see Additional File 1). The categories were grouped in 
this way for the ease of interpretation and to avoid having 
too few episodes in some categories. Episodes with age 
below 15  years or above 60  years were removed due to 
the low number of entries for these age groups. For each 
qualitative variable, the level that occurred the most fre-
quently in the 2015/2016 period was used as the baseline 
level in the logistic regression model.
Specifically, the logistic regression model uses
where β0 is the intercept term, β is the vector of coeffi-
cients and x is the vector of covariates. For covariates 
that do not interact with other variables, the estimated 
odds ratios were calculated as exp
(
βˆ
)
 , where βˆ is the 
estimated coefficient of a variable. When the covariates 
were fixed, the proportion of amphetamine treatment 
episodes can be estimated as
In all analyses, the level of significance was set at 5%. 
The analyses were carried out using R [18].
People’s names were removed prior to LLW supplying 
the data. Ethical approval to use de-identified data was 
granted by Charles Sturt University’s Human Research 
Ethics Committee (Protocol No. 2013/016).
Results
There were 2806, 3435 and 2681 closed treatment epi-
sodes in the three time periods, respectively. Among 
these episodes, amphetamine was the principal drug 
of concern in 412 (14.7%), 257 (7.5%) and 904 (33.7%) 
of the episodes in the datasets, respectively. This is a 
similar trend to the national treatment data of 12%, 9% 
and 23% during the respective time periods [11] while 
reported use in the Australian population has contin-
ued to fall from 2.5% in 2007 to 1.4% in 2016 [1]. How-
ever, a significantly higher percentage of episodes were 
for amphetamine treatment in the LLW 2015-16 dataset 
than were recorded nationally (Z = 13.8, p < 0.001). Treat-
ment episode data included an ‘other drug of concern’ 
log(odds(Amphetamine))
= log
[
P(Amphetamine)
1− P(Amphetamine)
]
= β0 + β
′
x,
Pˆ(Amphetamine) =
exp
(
βˆ0 + βˆ
′
x
)
1+ exp
(
βˆ0 + βˆ
′
x
) .
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category. Amphetamine decreased as a secondary drug 
over the study period. In 2006/2007, 470 people (20%) 
had amphetamine identified as a secondary drug of con-
cern. Whereas 472 people (15%) and 218 people (12%) 
identified amphetamine in 2010/2011 and 2015/2016, 
respectively.
Figure 1 shows the client profile of LLW according to 
the principal drug of concern, sex, age and Indigenous 
status. In 2015/2016, amphetamine overtook alcohol as 
the most common principal drug of concern. The propor-
tions of both female and Indigenous episodes increased 
over time. The proportion of episodes for people below 
30 years of age decreased overall.
Table 1 shows the characteristics of clients whose prin-
cipal drug of concern was amphetamine in the three time 
periods. Figure 2 shows the proportion of amphetamine 
episodes by sex and age in different periods estimated 
from the logistic regression model. Since these three 
variables interact with each other, the marginal effect of 
each variable depends on levels of the other variables. 
The estimated coefficients and the variance–covariance 
matrix of the coefficients are provided in Additional files 
2 and 3. This would allow computation of the marginal 
and interacting effects, following the method described 
in Norton et al. [19] and Karaca-Mandic et al. [20].
Table  2 shows the effects of the non-interacting vari-
ables on the odds of being treated for amphetamine 
estimated from the logistic regression models. The ref-
erence levels of qualitative variables define the “baseline 
characteristics” for a treatment episode as a non-Indig-
enous male who owned or rented a place for living, who 
lived with parents, friends or relatives, self-referred to 
the agency, and whose main source of income was not 
through employment.
Age and sex
The proportion of amphetamine treatment episodes 
in 2015/2016 was estimated to be the highest across 
Fig. 1 Snapshots of LLW client profiles in the three periods: principal drug of concern (top-left), sex (top-right), age (bottom-left), and Indigenous 
status (bottom-right)
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all ages for both sexes (Fig.  2). Meanwhile, in all peri-
ods, episodes for younger people were more likely to 
have amphetamine as the principal drug of concern, 
rather than other drugs (Fig. 2). In 2015/2016, the odds 
of having amphetamine as the principal drug of con-
cern was estimated to reduce by around 5% and 8% for 
every year increase in age for males and females, respec-
tively. For episodes provided to people under 40  years 
of age, there was a higher proportion of female clients 
with amphetamine as the principal drug of concern, 
compared to males. The trend reversed for episodes 
for people above 40 years of age (Fig. 2). The estimated 
proportion between male and female changed around 
age 25 in 2010/2011. This was different from the change 
that occurred around age 40 in both 2006/2007 and 
2015/2016 (Fig. 2). While our model estimated that most 
younger females were primarily treated for ampheta-
mine in 2015/2016 (Fig.  2), most of the treatment ser-
vices were provided to males (Table 1).
Indigenous status
The proportion of Indigenous people among ampheta-
mine treatment episodes increased from around 30 
to 40% over the 10-year period used in the analysis 
(Table  1). Indigenous people in treatment were likely 
to be younger and female compared to non-Indigenous 
people. There are no significant differences between 
Indigenous and non-Indigenous people in terms of the 
odds of being treated for amphetamine, after considering 
all other variables (Table 2).
Table 1 Characteristics of clients whose principal drug of concern was amphetamine
Significant differences in percentages within a row based on Marascuilo’s multiple comparison at a family-wise error rate of 5% are indicated by different alphabetical 
letters. The percentages may not sum up to 100 due to either rounding or missing values
Period 2006/2007 2010/2011 2015/2016
Number of episodes 412 257 904
Sex
Male (%) 69.7a 74.7b 64.8a
Female (%) 30.3b 25.3a 35.2b
Age
> 15 and ≤ 30 (%) 63.3b 46.3a 49.7a
> 30 and ≤ 45 (%) 35.0a 48.6a 46.2a
> 45 and ≤ 60 (%) 1.7a 5.1ab 4.1b
Indigenous
Yes (%) 29.4a 26.5a 40.0b
No (%) 68.9b 72.4b 60.0a
Living arrangement
Alone (%) 32.5 25.3 28.2
With parents or friends or relatives (%) 38.3a 49.4b 43.4b
With spouse/partner and/or child(ren) (%) 23.8 24.1 18.0
Unknown/others (%) 5.3b 1.2a 10.4c
Usual accommodation
Owned or rented (%) 77.9a 89.1b 79.3a
Temporary accommodation or homeless (%) 20.9b 10.1a 11.2a
Unknown/others (%) 1.2a 0.8a 9.5b
Source of referral
Self (%) 30.1a 42.8b 50.8b
Legal (%) 24.3 24.9 22.8
Health care (%) 13.6b 14.8b 6.6a
Other AOD (%) 19.4b 10.9a 10.3a
Others (%) 12.6b 6.6a 9.5ab
Source of income
Not through employment (%) 91.7b 89.1ab 84.6a
Through employment (%) 6.1 6.6 3.4
No income (%) 1.0a 3.9a 4.8b
Unknown (%) 1.2a 0.4a 7.2b
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Living arrangements and usual accommodation
Among the amphetamine treatments, there was a sig-
nificant increase in the proportion of episodes for people 
living with parents, friends or relatives in 2010/2011 and 
2015/2016, compared to 2006/2007 (Table  1). However, 
the logistic regression model showed that these living 
arrangements did not result in significantly different odds 
of being treated for amphetamine (Table 2).
Homeless people or those in temporary accommoda-
tion significantly reduced from around 20% in 2006/2007 
to around 10% in the following two periods (Table  1). 
However, the logistic regression model demonstrates that 
despite the reduction in overall numbers homeless peo-
ple or people in temporary accommodation are 1.8 times 
more likely to have amphetamine as their principal drug 
of concern compared to those owning or renting accom-
modation (Table 2).
Referral source
Among the amphetamine treatment episodes, most of 
the clients were self-referred. The proportion of self-
referrals significantly increased from around 30% in 
2006/2007 to around 50% of amphetamine treatment epi-
sodes in 2015/2016. Within the same period, the propor-
tion of episodes referred from health care settings and 
other AOD significantly dropped (Table 1). Compared to 
those who were self-referred, people who were referred 
from health care settings were significantly less likely to 
be treated for amphetamine (Table 2).
Source of income
Among the amphetamine treatment episodes, most peo-
ple had income through sources other than employment. 
Although the proportion dropped significantly from 92 
to 85% from 2006/2007 to 2015/2016, the proportion of 
Fig. 2 Estimated proportion of amphetamine treatment episodes for clients with baseline characteristics by sex and age in 2006/2007 (top-left), 
2010/2011 (top-right) and 2015/2016 (bottom)
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clients who did not have any income at all increased sig-
nificantly from 1 to 5% in the same period. Table 2 shows 
that, the odds of being treated for amphetamine for peo-
ple with income through employment was 0.38 times that 
for clients whose incomes were not through employment.
Discussion
Both the number and proportion of treatment episodes 
provided for amphetamine in the organisation studied 
has substantially increased over time. The proportion of 
treatment episodes provided for amphetamine was sig-
nificantly greater than the percentage reported nation-
ally [11]. There were changes over time in the age, sex 
and Indigenous status of people receiving treatment for 
amphetamine as the principal drug of concern. It is esti-
mated that more than half of treatment episodes pro-
vided for people aged 30 or below were for amphetamine. 
Alcohol was no longer the principal drug of concern for 
most treatment episodes. The reduction in amphetamine 
as a secondary drug of concern at the same time as it 
increased as a principle drug supports the idea that peo-
ple were experiencing more harms from methampheta-
mine as it became stronger and it became the main drug 
causing them problems. Many people in treatment are 
poly drug users and drug use patterns change according 
to what is available at the time.
The biggest change is in the proportions of younger 
women represented in the treatment episodes. While 
treatment episodes for amphetamine use have typically 
been provided to men younger than thirty-five there 
is now a high proportion of women in that group that 
exceeds the proportion of amphetamine treatment epi-
sodes provided to men. Women usually comprise around 
one-third of the treatment population overall and treat-
ment has been designed for the needs and preferences 
of men, particularly in residential treatment [21, 22]. For 
example, in the LLW residential units, vocational activi-
ties have a construction, mechanical and labouring focus; 
recreational activities are held in a weight lifting gym; 
and there are no facilities for children’s activities during 
weekend visits. In the treatment groups, relapse preven-
tion activities and role play primarily examine risks and 
triggers likely in pubs and sporting events while pro-
moting the role of female family members in support-
ing sobriety. The analysis and subsequent examination 
of psychosocial treatment activities has revealed the 
strongly gendered assumptions of the treatment activi-
ties. The needs and preferences for treatment of younger 
women who use amphetamines will be important factors 
in changing treatment for service providers who were 
used to providing treatment for young men who use can-
nabis and older men who use alcohol.
The nexus between child protection, criminal jus-
tice, domestic violence, child and family services and 
drug and alcohol problems is well documented [21, 8]. 
Younger women and men represented in the data used 
in this study are likely to have children in their care and/
or be involved with child protection agencies who will 
be monitoring the outcome of any treatment programs. 
With more younger women in treatment programs, 
understanding women’s experiences and outcomes from 
different treatment types would be useful for direct-
ing women into the most appropriate and effective ser-
vice types rather than assessing them on drug use alone. 
Child protection agencies may be a factor in increased 
amphetamine treatment episodes as women in particular 
are required to attend treatment to retain custody of their 
children.
Younger people in treatment services are likely to have 
different interests, concerns and healthcare needs com-
pared to older people who are dependent on alcohol. 
Physical problems and capacity to recover from illness 
and injury are highly likely to be different with younger 
Table 2 Effect estimates for  non-interacting variables 
from the logistic regression model
Residual deviance: 7073.1 on 8778 df. See also Additional file 2 for coefficient 
estimates for variables that interact with other variables. The p values were 
calculated based on z test
Odds Ratio 95% Wald CI p value
Indigenous
Yes 0.920 (0.808, 1.047) 0.207
No Ref – –
Living arrangement
Alone 0.923 (0.785, 1.085) 0.330
With spouse/partner and/or 
child(ren)
1.000 (0.850, 1.176) 0.999
Unknown/others 0.892 (0.628, 1.267) 0.522
With parents or friends or relatives Ref – –
Usual accommodation
Temporary accommodation or 
homeless
1.815 (1.473, 2.237) < 0.001
Unknown/others 0.683 (0.464, 1.006) 0.053
Owned or rented Ref – –
Source of referral
Legal 0.859 (0.734, 1.005) 0.057
Health care 0.777 (0.632, 0.955) 0.017
Other AOD 1.067 (0.879, 1.294) 0.512
Others 0.806 (0.652, 0.996) 0.046
Self Ref – –
Source of income
Through employment 0.357 (0.276, 0.463) < 0.001
No income 1.128 (0.801, 1.589) 0.490
Unknown 0.513 (0.372, 0.709) < 0.001
Not through employment Ref – –
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people less likely to have chronic illnesses. Homelessness, 
temporary or unstable accommodation, involvement 
with the legal sector and unemployment indicates many 
people in drug and alcohol treatment for amphetamine 
use will need a range of supports to change their cur-
rent circumstances [10, 13]. Substance treatment services 
will have to work in a collaborative and coordinated way 
with agencies and services outside the healthcare sector 
to improve and sustain treatment outcomes for people. 
Self -referral is the most common pathway into treatment 
services and few people are referred from other health 
services. This suggests a lack of coordination and coop-
eration between health and community sector agencies. 
LLW’s ideal workforce will be one that is experienced and 
knowledgeable in cross sector work as well as capable 
and permitted to respond to the situational factors peo-
ple in substance treatment are facing.
Capability to offer a culturally contextualised service is 
critical for Lives Lived Well. The number of Indigenous 
people represented in this study’s treatment episodes is 
a factor of location in regional NSW where the Indige-
nous population is one of the highest in Australia but also 
because Indigenous people are overrepresented in prob-
lem drug use statistics nationally [23, 11]. Strategies such 
as ensuring there are a proportion of Indigenous staff 
to match the number of clients and involving Elders in 
services and in consumer representation groups will be 
important to ensure that localised cultural practices are 
embedded within service delivery [15, 24].
The age and sex profile of alcohol treatment epi-
sodes is different to those of amphetamine episodes. 
While alcohol use has declined in Australia overall it is 
still the drug that causes the most harm after tobacco 
[11]. The proportion of episodes provided for alcohol 
by LLW has declined and the agency should consider 
if alcohol dependent people are unable to access treat-
ment because of the number of amphetamine treatment 
episodes being supplied. The public focus on ampheta-
mine use may have caused an increase in amphetamine 
treatment episodes. The Australian government Ice 
Taskforce investigations and reports generated sev-
eral national health promotion campaigns about harms 
associated with methamphetamine use. The campaigns 
included television advertising depicting amphetamine 
users being violent to others. These campaigns along-
side the media reports of an ‘ice epidemic’ may have 
resulted in more people seeking treatment in 2015/2016 
because they were made aware of both harms and treat-
ment options. Qualitative interviews with amphetamine 
users and staff of treatment centres could explore what 
drives trends in treatment episodes and how changes are 
responded to. This is an important area of research for 
the future.
Limitations
The study reports the results from an observational study 
that represents observed patterns in reported treatment 
episodes only. Any relationships reported should not be 
considered as causal relationships. Further, the recorded 
treatment episodes may include the same individual 
many times within the same and different treatment 
types. While this suggests that amphetamine users may 
access treatment more often it cannot be confirmed from 
the existing data. Therefore, the results should be inter-
preted with caution. Analyses using identified data and 
statistical linkage keys would assist with reporting treat-
ment usage and access patterns.
There are some questions arising from the study results 
that require further investigation. People come to the 
LLW rural services from all over New South Wales with 
more than half usually residing in rural or regional areas. 
There are consistent reports of higher methampheta-
mine use in rural areas [4]. The differences in treatment 
episodes between rural and urban dwellers were not 
examined in this study are important to include in future 
work. The age differences shown in Fig. 2 when the esti-
mated proportion of amphetamine treatment episodes 
between male and female in 2010/2011 changed around 
age 25 instead of age 40 in the other datasets is unex-
plained. Further analysis over time could identify if this 
was an anomaly or something that recurs.
Conclusion
Together with an increased number of amphetamine 
treatment episodes there were several changes in the 
characteristics of people using LLW treatment services. 
LLW must assess their treatment types to ensure they are 
contextualising service delivery to demand from younger 
people, particularly the needs of young women; are pro-
viding appropriate support for Indigenous people and 
addressing homelessness. Increased amphetamine treat-
ment episodes have been noted nationally. It is likely 
similar changes in the treatment population will be expe-
rienced in other agencies. All treatment services should 
review who demand is coming from and what is supplied 
to ensure the best treatment options are provided.
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